$TRDA SEC Filings

Filed On	Filing
14 Oct 2026	8-K: Regulation FD Disclosure; Other Events Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (DMD) in the Phase 1/2 ELEVATE-45-201 Study of ENTR-601-45
10 Sep 2026	SCHEDULE 13D/A
09 Sep 2026	Form 4: Mpm Bioventures 2018, L.p., 10% owner and 2 others Sold 38,500 shares ($274K) · Sold 192,500 shares ($1.43M) · Sold 28,837 shares ($206K)
09 Sep 2026	Form 4: Mpm BioVentures 2014, L.p., 10% owner and 9 others Sold 38,500 shares ($274K) · Sold 192,500 shares ($1.43M) · Sold 28,837 shares ($206K)
03 Sep 2026	Form 4: Mpm Bioventures 2018, L.p., 10% owner and 2 others Sold 29,088 shares ($205K) · Sold 25,131 shares ($181K) · Sold 32,263 shares ($231K)
03 Sep 2026	Form 4: Mpm BioVentures 2014, L.p., 10% owner and 9 others Sold 29,088 shares ($205K) · Sold 25,131 shares ($181K) · Sold 32,263 shares ($231K)
03 Sep 2026	Form 4: Doshi Dipal, Director Gave up 8,724 shares to cover exercise price or tax ($62.3K)
03 Sep 2026	Form 4: Dowden Nathan J, President & COO Gave up 2,528 shares to cover exercise price or tax ($18.1K)
03 Sep 2026	Form 4: Sethuraman Natarajan, President, Research & Develop. Gave up 2,079 shares to cover exercise price or tax ($14.9K)
03 Sep 2026	Form 4: Wentworth Kory James, Chief Financial Officer Gave up 1,733 shares to cover exercise price or tax ($12.4K)
31 Aug 2026	Form 4: Mpm Bioventures 2018, L.p., 10% owner and 2 others Sold 38,922 shares ($280K) · Sold 3,733 shares ($26.2K) · Sold 44,259 shares ($309K)
31 Aug 2026	Form 4: Mpm BioVentures 2014, L.p., 10% owner and 9 others Sold 38,922 shares ($280K) · Sold 3,733 shares ($26.2K) · Sold 44,259 shares ($309K)
26 Aug 2026	Form 4: Mpm BioVentures 2014, L.p., 10% owner and 9 others Sold 21,623 shares ($159K) · Sold 26,522 shares ($200K) · Sold 14,569 shares ($103K)
26 Aug 2026	Form 4: Mpm Bioventures 2018, L.p., 10% owner and 2 others Sold 21,623 shares ($159K) · Sold 26,522 shares ($200K) · Sold 14,569 shares ($103K)
14 Aug 2026	SCHEDULE 13G/A
10 Aug 2026	Form 4: Parmar Kush, Director Sold 10,494 shares ($73.5K) · Sold 52,317 shares ($358K) · Sold 92,444 shares ($647K)
10 Aug 2026	Form 4: 5AM Ventures V, L.p., 10% owner and 5 others Sold 10,494 shares ($73.5K) · Sold 52,317 shares ($358K)
10 Aug 2026	144/A
05 Aug 2026	10-Q
05 Aug 2026	8-K: Results of Operations and Financial Condition

Comments